We are live on ! Find out more
MML Investors Services

MML Investors Services Portfolio holdings

AUM $49B
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+25.55%
3 Year Est. Return
+74.45%
5 Year Est. Return
+77.86%
10 Year Est. Return
+280.52%
AUM
$11.9B
AUM Growth
+$1.44B
Cap. Flow
+$786M
Cap. Flow %
6.61%
Top 10 Hldgs %
17.19%
Holding
1,963
New
167
Increased
1,183
Reduced
528
Closed
69

Sector Composition

Rank Sector Weight
1 Technology 8.61%
2 Financials 4.9%
3 Consumer Discretionary 4.75%
4 Healthcare 4.64%
5 Communication Services 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RFIL icon
1876
RF Industries
RFIL
$139M
$79K ﹤0.01%
10,570
ETON icon
1877
Eton Pharmaceutcials
ETON
$1.22B
$71K ﹤0.01%
11,500
JNCE
1878
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$68K ﹤0.01%
+10,000
New +$83.1K
MFG icon
1879
Mizuho Financial
MFG
$130B
$67K ﹤0.01%
23,613
+4,565
+24% +$13.6K
LPCN icon
1880
Lipocine
LPCN
$17.6M
$64K ﹤0.01%
2,706
+294
+12% +$6.91K
AMRN
1881
Amarin Corp
AMRN
$303M
$54K ﹤0.01%
619
NMR icon
1882
Nomura Holdings
NMR
$29.1B
$53K ﹤0.01%
10,472
+401
+4% +$2.16K
BXRX
1883
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$43K ﹤0.01%
40
+8
+25% +$10.5K
SENS icon
1884
Senseonics Holdings Inc
SENS
$366M
$38K ﹤0.01%
500
INFI
1885
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$32K ﹤0.01%
10,741
NMTR
1886
DELISTED
9 Meters Biopharma
NMTR
$22K ﹤0.01%
1,000
ABEO icon
1887
Abeona Therapeutics
ABEO
$413M
$16K ﹤0.01%
+400
New +$16.3K
CXDC
1888
DELISTED
China XD Plastics Company Limited
CXDC
$12K ﹤0.01%
20,000
GAB.RT
1889
DELISTED
The Gabelli Equity Trust Inc. Rights (expiring July 14, 2021)
GAB.RT
$5K ﹤0.01%
+42,550
New +$4.94K
AOA icon
1890
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.28B
-3,122
Closed -$209K
EFOR
1891
Everforth Inc
EFOR
$1.32B
-3,018
Closed -$288K
ATHM icon
1892
Autohome
ATHM
$2.62B
-5,112
Closed -$477K
AVK
1893
Advent Convertible and Income Fund
AVK
$563M
-31,711
Closed -$546K
AXDX
1894
DELISTED
Accelerate Diagnostics
AXDX
-1,119
Closed -$93K
BCRX icon
1895
BioCryst Pharmaceuticals
BCRX
$2.4B
-10,000
Closed -$102K
BSCR icon
1896
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.59B
-10,347
Closed -$224K
BUG icon
1897
Global X Cybersecurity ETF
BUG
$1.46B
-8,647
Closed -$217K
BWG
1898
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$131M
-10,671
Closed -$129K
CBRL icon
1899
Cracker Barrel
CBRL
$1.29B
-1,510
Closed -$261K
CPB icon
1900
Campbell Soup
CPB
$6.87B
-5,687
Closed -$286K

Similar funds

MML Investors Services's Q2 2021 Portfolio in Review

As of Q2 2021, MML Investors Services held 1,963 positions worth $11.9B, up 14% from $10.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MML Investors Services deployed $786M of net new capital in Q2 2021, opening 167 new positions and adding to 1,183 existing holdings. Its largest new stake was iShares Global Financials ETF: 505,633 shares worth $39.2M.

By sector, the portfolio is most concentrated in Technology at 8.6% of assets, up from 8.2% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $30M trimmed.

  • MML Investors Services's largest Q2 2021 buy was iShares Global Financials ETF: 505,633 shares worth $39.2M.
  • MML Investors Services added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $39.9M increase.
  • MML Investors Services's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $30M.
  • MML Investors Services fully exited iShares US Oil Equipment & Services ETF in Q2 2021, selling an estimated $6.93M.
  • MML Investors Services's ten largest holdings make up 17% of its $11.9B portfolio in Q2 2021.
  • MML Investors Services opened 167 new positions and closed 69 in Q2 2021.
  • MML Investors Services's portfolio value rose 14% quarter-over-quarter to $11.9B.

Based on MML Investors Services's 13F filing for Q2 2021, filed 13 Aug 2021.